Klara Dalva

2.2k total citations
73 papers, 649 citations indexed

About

Klara Dalva is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Klara Dalva has authored 73 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Hematology, 22 papers in Immunology and 14 papers in Genetics. Recurrent topics in Klara Dalva's work include Hematopoietic Stem Cell Transplantation (24 papers), Immune Cell Function and Interaction (12 papers) and Multiple Myeloma Research and Treatments (11 papers). Klara Dalva is often cited by papers focused on Hematopoietic Stem Cell Transplantation (24 papers), Immune Cell Function and Interaction (12 papers) and Multiple Myeloma Research and Treatments (11 papers). Klara Dalva collaborates with scholars based in Türkiye, United States and Czechia. Klara Dalva's co-authors include Meral Beksaç, Doğan Yücel, Mutlu Arat, Hamdi Akan, Muhıt Özcan, Osman İlhan, Önder Arslan, Meral Beksaç, Pervin Topçuoğlu and Günhan Gürman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Klara Dalva

66 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klara Dalva Türkiye 13 231 159 111 108 106 73 649
Kendall P. Crookston United States 14 232 1.0× 129 0.8× 64 0.6× 88 0.8× 183 1.7× 36 776
Zane Kaplan Australia 11 289 1.3× 140 0.9× 80 0.7× 77 0.7× 83 0.8× 28 692
Miho Sakakura Japan 15 315 1.4× 135 0.8× 101 0.9× 87 0.8× 58 0.5× 35 680
Jevgenia Zilberman‐Rudenko United States 13 206 0.9× 89 0.6× 97 0.9× 50 0.5× 107 1.0× 27 499
Junji Tomiyama Japan 13 235 1.0× 153 1.0× 100 0.9× 69 0.6× 110 1.0× 47 565
Antonio Sánchez United States 6 342 1.5× 249 1.6× 152 1.4× 80 0.7× 66 0.6× 20 1.0k
J Fehr Switzerland 10 322 1.4× 130 0.8× 96 0.9× 69 0.6× 68 0.6× 27 698
Giusy Peluso Italy 18 205 0.9× 290 1.8× 68 0.6× 155 1.4× 137 1.3× 42 1.1k
Raffaella Monno Italy 14 147 0.6× 143 0.9× 92 0.8× 109 1.0× 126 1.2× 18 832
Kristina L. Modjeski United States 7 259 1.1× 164 1.0× 41 0.4× 79 0.7× 156 1.5× 9 737

Countries citing papers authored by Klara Dalva

Since Specialization
Citations

This map shows the geographic impact of Klara Dalva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klara Dalva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klara Dalva more than expected).

Fields of papers citing papers by Klara Dalva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klara Dalva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klara Dalva. The network helps show where Klara Dalva may publish in the future.

Co-authorship network of co-authors of Klara Dalva

This figure shows the co-authorship network connecting the top 25 collaborators of Klara Dalva. A scholar is included among the top collaborators of Klara Dalva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klara Dalva. Klara Dalva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dalva, Klara, et al.. (2024). Common human leucocyte antigensassociated with the development of subacute thyroiditis and COVID-19. Human Immunology. 85(4). 110834–110834.
2.
3.
Seval, Güldane Cengiz, Klara Dalva, Şule Mine Bakanay, et al.. (2021). Post-Induction Undetectable Minimal Residual Disease at 10 -5 Sensitivity Level within Marrow and/or Stem Cell Graft Overrides Cytogenetic High Risk. Blood. 138(Supplement 1). 2909–2909. 1 indexed citations
4.
Örgül, Gökçen, et al.. (2021). Significance of inhibitory maternal killer-cell immunoglobulin-like receptor (KIR) and fetal KIR ligand genotype combinations in placenta related obstetric complications. Journal of Reproductive Immunology. 148. 103425–103425. 2 indexed citations
5.
İlhan, Osman, et al.. (2021). Leukemic stem cells shall be searched in the bone marrow before “tyrosine kinase inhibitor‐discontinuation” in chronic myeloid leukemia. International Journal of Laboratory Hematology. 43(5). 1110–1116. 7 indexed citations
6.
Beksac, Meral, Güldane Cengiz Seval, İrem Akdemir Kalkan, et al.. (2021). A model integrating Killer Immunoglobulin-like Receptor (KIR) haplotypes for risk prediction of COVID-19 clinical disease severity. Immunogenetics. 73(6). 449–458. 4 indexed citations
7.
Haskoloğlu, Şule, Sevgi Köstel Bal, Funda Çipe, et al.. (2021). Single-Center Study of 72 Patients with Severe Combined Immunodeficiency: Clinical and Laboratory Features and Outcomes. Journal of Clinical Immunology. 41(7). 1563–1573. 7 indexed citations
8.
Sak, Serpil Dızbay, Hakan Korkmaz, Özgür Demir, et al.. (2020). Long-Term Outcomes of Tamoxifen Citrate Therapy and Histo- and Immunopathological Properties in Riedel Thyroiditis. European Thyroid Journal. 10(3). 248–256. 4 indexed citations
9.
Seval, Güldane Cengiz, et al.. (2020). Pleural Involvement Upon Relapse of Myeloma Responding to Daratumumab Plus Carfilzomib: A Case Presentation and Literature Review. Clinical Lymphoma Myeloma & Leukemia. 21(3). e267–e271.
10.
Varan, Hacer Doğan, et al.. (2019). Comparison of the methods evaluating post thawing viability of peripheral blood stem cell graft. Transfusion and Apheresis Science. 58(2). 192–195. 8 indexed citations
11.
Elçin, Ayşe Eser, Mahmut Parmaksız, Arın Doğan, et al.. (2017). Differential gene expression profiling of human adipose stem cells differentiating into smooth muscle-like cells by TGFβ1/BMP4. Experimental Cell Research. 352(2). 207–217. 11 indexed citations
12.
Dalva, Klara, et al.. (2016). Flow Cytometric Aldehyde Dehydrogenase Assay Enables a Fast and Accurate Human Umbilical Cord Blood Hematopoietic Stem Cell Assessment. Turkish Journal of Hematology. 34(4). 314–320. 2 indexed citations
13.
Sarı, Neriman, et al.. (2013). Comparison of Filgrastim and Lenograstim in Pediatric Solid Tumors. Pediatric Hematology and Oncology. 30(7). 655–661. 5 indexed citations
14.
Durdu, Serkan, Klara Dalva, Arın Doğan, et al.. (2011). Effects of Preoperative Short Term Use of Atorvastatin on Endothelial Progenitor Cells after Coronary Surgery: A Randomized, Controlled Trial. Stem Cell Reviews and Reports. 8(3). 963–971. 51 indexed citations
15.
Soydan, Ender, Klara Dalva, Pervin Topçuoğlu, et al.. (2007). Impact of harvest product volume in erythrocyte depletion of allogeneic or autologous bone marrow using COBE spectra. Transfusion and Apheresis Science. 36(3). 269–273. 8 indexed citations
16.
Topçuoğlu, Pervin, Ender Soydan, Fuat Ekız, et al.. (2007). How to calculate the quantity of CD34+ cells infused? A single center cohort study based on actual, ideal or adjusted ideal body weight. Transfusion and Apheresis Science. 36(3). 275–280. 3 indexed citations
17.
Dalva, Klara & Meral Beksaç. (2007). Sequence-Specific Primed PCR (PCR-SSP) Typing of HLA Class I and Class II Alleles. Methods in molecular medicine. 134. 51–60. 4 indexed citations
18.
Kızıltepe, Uğursay, et al.. (2001). Effects of combined conventional and modified ultrafiltration in adult patients. The Annals of Thoracic Surgery. 71(2). 684–693. 51 indexed citations
19.
Demirer, Taner, Osman İlhan, Mutlu Arat, et al.. (2001). CD41+ and CD42+ hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation. Journal of Clinical Apheresis. 16(2). 67–73. 15 indexed citations
20.
Arslan, Önder, Hamdi Akan, Mutlu Arat, et al.. (2000). Soluble adhesion molecules (sICAM-1, sL-Selectin, sE-Selectin, sCD44) in healthy allogenic peripheral stem-cell donors primed with recombinant G-CSF. Cytotherapy. 2(4). 259–265. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kendall P. Crookston Breakdown of academic impact, for papers by Zane Kaplan Breakdown of academic impact, for papers by Miho Sakakura Breakdown of academic impact, for papers by Jevgenia Zilberman‐Rudenko Breakdown of academic impact, for papers by Junji Tomiyama Breakdown of academic impact, for papers by Antonio Sánchez Breakdown of academic impact, for papers by J Fehr Breakdown of academic impact, for papers by Giusy Peluso Breakdown of academic impact, for papers by Raffaella Monno Breakdown of academic impact, for papers by Kristina L. Modjeski
Rankless by CCL
2026